Corcept Therapeutics (CORT) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Corcept Therapeutics (CORT) over the last 10 years, with Q3 2025 value amounting to $0.16.
- Corcept Therapeutics' EPS (Weighted Average and Diluted) fell 6097.56% to $0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.87, marking a year-over-year decrease of 3095.24%. This contributed to the annual value of $1.23 for FY2024, which is 3099.41% up from last year.
- Per Corcept Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at $0.16 for Q3 2025, which was down 6097.56% from $0.29 recorded in Q2 2025.
- Over the past 5 years, Corcept Therapeutics' EPS (Weighted Average and Diluted) peaked at $0.41 during Q3 2024, and registered a low of $0.14 during Q4 2022.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.25 (2023), whereas its average is $0.24.
- As far as peak fluctuations go, Corcept Therapeutics' EPS (Weighted Average and Diluted) skyrocketed by 10000.0% in 2023, and later plummeted by 6097.56% in 2025.
- Quarter analysis of 5 years shows Corcept Therapeutics' EPS (Weighted Average and Diluted) stood at $0.26 in 2021, then crashed by 46.15% to $0.14 in 2022, then skyrocketed by 100.0% to $0.28 in 2023, then fell by 4.36% to $0.27 in 2024, then tumbled by 40.25% to $0.16 in 2025.
- Its last three reported values are $0.16 in Q3 2025, $0.29 for Q2 2025, and $0.17 during Q1 2025.